Page last updated: 2024-09-04
l 738167 and mk 0852
l 738167 has been researched along with mk 0852 in 1 studies
Compound Research Comparison
| Studies (l 738167) | Trials (l 738167) | Recent Studies (post-2010) (l 738167) | Studies (mk 0852) | Trials (mk 0852) | Recent Studies (post-2010) (mk 0852) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 17 | 2 | 0 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bednar, B; Bednar, RA; Egbertson, MS; Gaul, SL; Gould, RJ; Hamill, TG; Hartman, GD; Shafer, JA | 1 |
Other Studies
1 other study(ies) available for l 738167 and mk 0852
| Article | Year |
|---|---|
Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Topics: Azepines; Binding, Competitive; Blood Platelets; Fibrinolytic Agents; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thiazolidines | 1998 |